GlaxoSmithKline Antitrust Probe Dropped by EU Commission - Bloomberg

The European Commission said it ended an antitrust probe into GlaxoSmithKline Plc (GSK) over possible collusion to keep cheaper copies of medicines off the market after a complaint against the company was withdrawn.

“The Commission examined whether there may have been violation of EU competition law by GlaxoSmithKline,” Antoine Colombani, a spokesman for the regulator, said in an e- mail. The case involving generic-drug producer Synthon BV concerned “possible anticompetitive agreements or concerted practices in order to delay or exclude generic competition,” he said. Colombani declined to elaborate on Synthon’s role in the probe.

The announcement comes a day after European Union regulators dropped a similar probe into AstraZeneca Plc (AZN), the U.K.’s second-biggest drugmaker, and Takeda Pharmaceutical Co. (4502)’s Nycomed unit over possible collusion to keep cheaper copies of medicines off the market. That case was brought to a halt because of a lack of evidence.

via bloomberg.com

Posted via email from Jack's posterous